Acute administration of the psychotomimetic phencyclidine (PCP) can mimic some features of schizophrenia, while a repeated treatment regimen of PCP may provide a more effective way to model in animals the enduring cognitive dysfunction observed in many schizophrenic patients. The present study aims to investigate behavioural and neuropathological effects of sub-chronic PCP administration. The cognitive deficit induced by sub-chronic PCP was examined using a previously established operant reversal-learning paradigm. Subsequently, the effect of sub-chronic PCP on parvalbumin-immunoreactive (parvalbumin-IR) neurons was assessed using immunohistochemical techniques. Rats were trained to respond for food in an operant reversal-learning paradigm for approximately 6 weeks, followed by sub-chronic administration of PCP (2mg/kg) or vehicle twice daily for 7 days followed 7 days later by behavioural testing. Six weeks post PCP, brains were analysed using immunohistochemical techniques to determine the size and density of parvalbumin-IR in the frontal cortex and hippocampus. Sub-chronic PCP significantly reduced (p <0.001) percentage correct responding in the reversal phase relative to the initial phase, an effect that persisted throughout the experimental period (4 weeks). The density of parvalbumin-IR neurons was reduced in the hippocampus, with significant reductions in the dentate gyrus and CA2/3 regions (p <0.001). There were significant changes in the frontal cortex, with a reduction (p <0.01) in the M1 (motor area 1) region and increases in the M2 (motor area 2) region and cingulate cortex (p <0.01-p <0.001). These results parallel findings of profound hippocampal and more subtle cortical deficits of parvalbumin-IR neurons in schizophrenia, and provide evidence to suggest that sub-chronic PCP can induce a lasting cognitive deficit, an effect that may be related to the observed neuronal deficits.
Abdul-Monim Z, Reynolds G P, Neill J C (2003a) The atypical antipsychotic ziprasidone, but not haloperidol, improves PCP-induced cognitive deficits in a reversal learning task in the rat. J Psychopharmacology17: 57–66
2.
Abdul-Monim Z, Neill J C, Reynolds G P (2003b) The novel antipsychotic ziprasidone but not haloperidol reverses a selective cognitive deficit induced by sub-chronic PCP. J Psychopharmacology17 (Suppl. 3): A46-A46
3.
Abdul-Monim Z, Reynolds G P, Neill J C (2006): The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm. Behav Brain Res169: 263–273
4.
Ballmaier M, Zoli M, Mazzoncini R, Gennarelli M, Spano F (2001) Combined alpha 2-adrenergic/D2 dopamine receptor blockade fails to reproduce the ability of clozapine to reverse phencyclidine-induced deficits in prepulse inhibition of startle. Psychopharmacology159: 105–110
5.
Beasley C L, Reynolds G P (1997) Parvalbumin-immunoreactive neurones are reduced in the prefrontal cortex of schizophrenia. Schiz Res24: 349–355
6.
Beasley C L, Zhang Z, Patten I, Reynolds G P (2002) Selective deficits in pre-frontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins. Biol Psychiat52: 708–715
7.
Benes F M, Berretta S (2001) GABAergic interneurones: Implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology25: 1–27
8.
Benes F M, McSparren J, Bird E D, SanGiovanni J P, Vincent S L (1991) Deficits in small interneurons in prefrontal and cingulated cortices of schizophrenic and schizoaffective patients. Arch Gen Psych48: 996–1001
9.
Birrell J M, Brown VJ (2000) Medial frontal cortex mediates perceptual attentional set shifting in the rat. J Neurosci. 20: 4320–4324
10.
Braff D L, Heaton R, Kuck J (1991) The generalised pattern of neuropsychological deficit in outpatients with chronic schizophrenia with heterogeneous Wisconsin Card Sorting Test results. Arch Gen Psych47: 181–188
11.
Castellani S, Adams P M (1981) Acute and chronic phencyclidine effects on locomotor activity, stereotypy and ataxia in rats. Eur J Pharmacol73: 143–154
12.
Cochran S M, Fujimura M, Morris B J, Pratt J A (2002) Acute and delayed effects of phencyclidine upon mRNA levels of markers of glutamatergic and GABAergic neurotransmitter function in the rat brain. Synapse46: 206–214
13.
Cochran S M, Kennedy M, McKerchar C E, Steward L J, Pratt J A, Morris B J (2003) Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs. Neuropsychopharmacology28: 265–275
14.
Corcoran R, Upton D (1993) A role for the hippocampus in card sorting?Cortex29: 293–304
15.
Dias R, Robbins T W, Roberts A C (1996) Primate analogue of the Wisconsin Card Sorting Test: effects of excitotoxic lesions of the pre-frontal cortex in the marmoset. Behav Neurosci110: 872–886
16.
Egerton A, Reid L, McKerchar C E, Morris B J, Pratt J A (2005) Impairment in perceptual attentional set-shifting following PCP administration: a rodent model of set-shifting deficits in schizophrenia. Psychopharmacology179: 77–84
17.
Ehrhardt J, Sabel B A, Schroeder U (1999) Subchronically applied phencyclidine fails to disrupt prepulse inhibition in rats. Eur Neuropsychopharm10: 69–74
18.
Ellison G D, Eison M S (1983) Continuous amphetamine intoxication: an animal model of acute psychotic episode. Psychol Med13: 751–761
19.
Freidman H R, Goldman-Rakic P S (1994) Co-activation of prefrontal cortex and inferior parietal cortex in working memory tasks revealed by 2DG functional mapping in rhesus monkey. J Neurosci14: 2775–2788
20.
Freund T F, Buzsaki (1996) Interneurones of the hippocampus. Hippocampus6: 347–370
21.
Geyer M A, Krebs-Thomson K, Braff D L, Swerdlow N R (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology156: 117–154
22.
Goldberg T E, Weinberger D R, Breman K F (1987) Further evidence for dementia of the prefrontal type in schizophrenia? A controlled study of teaching the Wisconsin Card Sorting Test. Arch Gen Psychiat44: 1008–1014
23.
Goldman-Rakic P S (1999) The psychic neuron of the cerebral cortex. Ann N Y Acad Sci868:13–26
24.
Granon S, Vidal C, Thinus-Blanc C, Changeux J P, Poucet B (1994) Working memory, response selection, an effortful processing in rats with medial prefrontal lesions. Behav. Neurosci. 108: 883–891
25.
Grunze H C, Rainnie D G, Hasselmo M E, Barkai E, Hearn E F, McCarley R W, Greene R W (1996) NMDA-dependent modulation of CA1 local circuit inhibition. J Neurosci16: 2034–2043
26.
Idris N F, Repeto P, Neill J C, Large C H (2005) Investigation of the effects of lamotrigine and clozapine to improve reversal learning impairments induced by acute PCP and d-amphetamine in the rat. Psychopharmacology179: 336–348
27.
Jackson P A, Kesner R P, Amann K (1998) Memory for duration: role of hippocampus and medial prefrontal cortex. Neurobiol Learn Mem.70: 328–348
28.
Javitt D C, Zukin S R (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiat148: 1301–1308
29.
Jentsch, J D, Roth R H (1999) The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology20: 201–225
30.
Jentsch J D, Taylor J R (2001) Impaired inhibition of conditioned responses produced by sub-chronic administration of phencyclidine to rats. Neuropsychopharmacology24: 66–74
31.
Jentsch J D, Tran A, Le D, Youngren K D, Roth R H (1997a) Sub-chronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat. Neuropsychopharmacology17: 92–99
32.
Jentsch J D, Dazzi L, Chhatwal J P, Verrico C D, Roth R H (1998) Reduced prefrontal cortical dopamine, but not acetylcholine, release in vivo after repeated, intermittent phencyclidine administration to rats. Neurosci Lett258: 175–178
33.
Jentsch J D, Redmond D E, Elsworth J D, Taylor J R, Younren K D, Roth R H (1997b) Enduring cognitive deficits and cortical dopamine dys-function in monkeys after long-term administration of phencyclidine. Science277: 953–955
34.
Jones G H, Marsden C A, Robbins T W (1991) Behavioural rigidity and rule-learning deficits following isolation-rearing in the rat: neurochemical correlates. Behav Brain Res43: 35–50
35.
Kesner R P, Dakis M (1997) Intrahippocampal injections of phencyclidine but not naloxone disrupt acquisition of a spatial continuous recognition memory task. Pharmacol Biochem Behav56: 97–101
36.
Kolb B (1984) Functions of the frontal cortex of the rat: a comparative review. Brain Res Rev8: 65–98
37.
Krystal J H, Harper L P, Seibyl J P, Freeman G K, Delaney R, Bremner J D, Heninger G R, Bowers M B, Charney D S (1994) Sub-anaesthetic effects of the non-competitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive and neuroendocrine responses. Arch Gen Psychiat51: 199–214
38.
Li L, Shao J (1998) Restricted lesions to the ventral pre-frontal sub areas block reversal learning but not visual discrimination learning in rats. Physiol Behav65: 371–379
39.
Manes F, Sahakian B, Clark L, Rogers R, Antoun N, Aitken M, Robbins T W (2002) Decision-making process following damage to the prefrontal cortex. Brain125: 624–639
40.
Martinez Z A, Ellison G D, Geyer M A, Swerdlow N R (1999) Effects of sustained phencyclidine exposure on sensorimotor gating of startle in rats. Neuropsychopharm21: 28–39
41.
Martinez Z A, Halim N D, Oostwegel J L, Geyer M A, Swerdlow N R (2000) Ontogeny of phencyclidine and apomorphine-induced startle gating deficits in rats. Pharmacol Biochem Behav65: 449–457
42.
Morita T, Sonoda R, Nakato K, Koshiya K, Wani buchi F, Yamaguchi T (2000) Phencyclidine-induced abnormal behaviours in rats as measured by the hole board apparatus. Psychopharmacology148: 281–288
43.
Olney J W, Newcomer J W, Farber N B (1999) NMDA receptor hypofunction model of schizophrenia. J Psych Res33: 523–533
44.
Owen A M, Roberts A C, Hodges J R, Summers B A, Polkey C E, Robbins TW (1993) Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease. Brain116: 1159–1175
45.
Pantelis C, Maruff P (2002) The cognitive neuropsychiatric approach to investigating the neurobiology of schizophrenia and other disorders. J Psychosom Res53(2): 655–664
46.
Pantelis C, Wood S J, Maruff P (2002) Schizophrenia. In Harrison J E, Owen A M (eds), Cognitive Deficits in Brain Disorders. Martin Dunitz,: London, pp. 217–248
47.
Paxinos G, Watson C (1986) The Rat Brain in Stereotaxic Co-ordinates, 2nd edn.Academic Press Inc., New York
48.
Qin Z H, Zhang S P, Weiss B (1994) Dopaminergic and glutamatergic blocking drugs differentially regulate glutamic acid decarboxylase mRNA in mouse brain. Mol Brain Res21: 293–302
49.
Rao S G,Williams G V, Goldman-Rakic P S (1999) Isodirectional tuning of adjacent interneurones and pyramidal cells during working memory: evidence for microcolumnar organization in prefrontal cortex. J Neurophysiol81: 1903–1916
50.
Rao S G, Williams G V, Goldman-Rakic P S (2000) Destruction and creation of spatial tuning by disinhibition: GABA(A) blockade of pre-frontal cortical neurones engaged by working memory. J Neurosci20: 485–494
51.
Redmond A M, Harkin A, Kelly J P, Leonard B E (1999) Effects of acute and chronic antidepressant administration on phencyclidine (PCP) induced locomotor hyperactivity. Eur Neuropsychopharmacology9: 165–170
52.
Reynolds G P, Beasley C L (2001) GABAergic neuronal subtypes in the human frontal cortex – development and deficits in schizophrenia. J Neurochem Anat22: 95–100
53.
Reynolds G P, Zhang Z J, Beasley C L (2001) Neurochemical correlates of cortical GABAergic deficits in schizophrenia: Selective losses of calcium binding protein immunoreactivity. Brain Res Bull55: 579–584
54.
Reynolds G P, Abdul-Monim Z, Neill J C, Zhang Z J (2004) Calcium binding protein markers of GABA deficits in schizophrenia – post mortem studies and animal models. Neurotoxicity6(1): 1–6
55.
Rodefer J S, Murphy E R, Baxter M G (2005) PDE10A inhibition reverses sub-chronic PCP-induced deficits in attentional set-shifting in rats. Eur J Neurosci21:1070–1076
56.
Schroeder U, Schroeder H, Schwegler H, Sabel B A (2000) Neuroleptics ameliorate phencyclidine-induced impairments of short-term memory. Br J Pharmacol130: 33–40
57.
Steinpreis R E (1996): The behavioural and neurochemical effects of phencyclidine in humans and animals: some implications for modelling psychosis. Behav Brain Res74: 45–55
58.
Sturgeon R D, Fessler R G, London S F, Meltzer H Y (1982) Behavioural effects of chronic phencyclidine administration in rats. Psychopharmacology76: 52–56
59.
Sziklas V, Petrides M (2002) Effects of lesions to the hippocampus or the fornix on allocentric conditional associative learning in rats. Hippocampus12: 543–550
60.
Weinberger D R, Berman K F, Zec R F (1986) Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia, I. Regional cerebral blood flow evidence. Arch Gen Psychiat43: 114–124
61.
Yamaguchi K, Nabeshima T, Kameyama T (1986) Role of dopaminergic and GABAergic mechanisms in discrete brain areas on phencyclidineinduced locomotor stimulation and turning behaviour. J Pharmacobiodyn9: 975–986
62.
Yu B, Wang C, Liu J, Johnson K M, Gallagher J P (2002) Adaptation to chronic PCP results in hyperfunctional NMDA and hypofunctional GABA(A) synaptic receptors. Neuroscience113: 1–10
63.
Zhang Z J, Reynolds G P (2002) A selective decrease in the relative density of parvalbumin-immunoreactive interneurons in the hippocampus in schizophrenia. Schizophr Res55: 1–10
